Assignee
TROVAGENE INC
US·8 granted patents·11 pending applications·212 citations·filing 2005–2016
Top patents by PatentIndex Score
19 records- 0195US7803929B2Kits for diagnosis and monitoring of pathogenic infection by analysis of cell-free pathogenic nucleic acids in urineTROVAGENE INC·Filed 2005·Granted Sep 28, 2010·132 cites·10 claims
- 0293US7973154B2Kits for diagnosis and monitoring of viral infection by analysis of viral transrenal nucleic acids in urineTROVAGENE INC·Filed 2005·Granted Jul 5, 2011·31 cites·11 claims
- 0389US7914982B2Methods for detecting pathogen specific nucleic acids in urineTROVAGENE INC·Filed 2006·Granted Mar 29, 2011·24 cites·4 claims
- 0486US8383335B2Method for diagnosis and monitoring of viral infection by analysis of viral transrenal nucleic acids in urineTROVAGENE INC·Filed 2011·Granted Feb 26, 2013·4 cites·18 claims
- 0585US9725755B2Synthesis and enrichment of nucleic acid sequencesTROVAGENE INC·Filed 2016·Granted Aug 8, 2017·17 cites·20 claims
- 0684US9453265B2Method for detection of high risk human papillomavirusTROVAGENE INC·Filed 2014·Granted Sep 27, 2016·3 cites·15 claims
- 0771US9816148B2Amplification and sequencing of transrenal nucleic acidsTROVAGENE INC·Filed 2015·Granted Nov 14, 2017·1 cites·18 claims
- 0859US2016060717A1Amplification and Sequencing of Transrenal Nucleic AcidsTROVAGENE INC·Filed 2013·Application pending·0 cites
- 0957US2017016078A1Method for detection of human papillomavirusTROVAGENE INC·Filed 2016·Application pending·0 cites
- 1055US2016273022A1Synthesis and enrichment of nucleic acid sequencesTROVAGENE INC·Filed 2014·Application pending·0 cites
- 1153US9909118B2Compositions, methods and kits for isolating nucleic acids from body fluids using anion exchange mediaTROVAGENE INC·Filed 2015·Granted Mar 6, 2018·0 cites·14 claims
- 1252US2015376725A1HPV Detection in UrineTROVAGENE INC·Filed 2013·Application pending·0 cites
- 1349US2015139946A1Detecting mutations in disease over timeTROVAGENE INC·Filed 2014·Application pending·0 cites
- 1447US2015132256A1Detecting and monitoring mutations in histiocytosisTROVAGENE INC·Filed 2014·Application pending·0 cites
- 1536US2018087114A1Early assessment of mechanism of action and efficacy of anti-cancer therapies using molecular markers in bodily fluidTROVAGENE INC·Filed 2016·Application pending·0 cites
- 1636US2016115556A1Detecting mutations in disease over timeTROVAGENE INC·Filed 2016·Application pending·0 cites
- 1734US2017096661A1Concentrating nucleic acids in urineTROVAGENE INC·Filed 2016·Application pending·0 cites
- 1834US2015344957A1Monitoring treatment of histiocytosis with vemurafenib and dabrafenibTROVAGENE INC·Filed 2015·Application pending·0 cites
- 1931US2016002740A1Detection of nucleic acids in urineTROVAGENE INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when TROVAGENE INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →